You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  NEUROLOGICAL REVIEW
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Neuroepidemiology

III. Decisions

Christopher D. Koprowski, MD, MBA; W. T. Longstreth, Jr, MD, MPH; Randall D. Cebul, MD

Arch Neurol. 1989;46(2):223-229.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AS we assemble clinical information on diagnosis and outcomes of neurologic conditions, we need to make decisions about further evaluation and treatment despite the existence of substantial uncertainty. We are all familiar with the uncertainty that surrounds clinical situations. Astute neurologists formulate a strategy based not only on data from the literature, but also on their own knowledge of basic science and clinical circumstances. The latter include not only an estimation of the likelihood of particular diagnosis, but also consideration of the patient's attitudes toward illness and death, the trade-off of high short-term risks with lower long-term risks, and a host of other factors. Most often neurologists attempt to analyze these factors intuitively and reach a decision about further evaluation or treatment based on as many relevant variables as possible.

Consider the patient who has experienced a transient ischemic attack.1 What is the best strategy for such a . . . [Full Text PDF of this Article]


Author Affiliations

From the Departments of Radiation Oncology and Neurology, Hahnemann University, Philadelphia (Dr Koprowski); Division of Neurology, Department of Medicine, University of Washington, Seattle (Dr Longstreth); and Division of General Medicine, Department of Medicine, Cleveland Metropolitan General Hospital (Dr Cebul).


Footnotes

Accepted for publication June 6, 1988.

Reprint requests to Division of Neurology, ZA-95 Harborview Medical Center, 325 Ninth Ave, Seattle, WA 98104 (Dr Longstreth).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.